CSI Market
Sign In | Register

Fennec Pharmaceuticals Inc (FENC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access FENC Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Fennec Pharmaceuticals Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income2.17
Depreciation & amortization0.00
Amortization of Other Assets0.05
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed-0.34
Increase (Decrease) in Inventories0.81
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.76
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.02
Gain Loss On Derivative Instruments Net Pretax-
Amortization Of Tenant Inducements Received-
Amortization Of Norgine Asset-
Realized Gain On Available For Sale Securities-
Available For Sale Debt Securities Gross Unrealized Loss0.00
Increase Decrease In Contract With Customer Liability-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.30
Increase (Decrease) in Accounts Payable0.88
Increase (Decrease) in Accrued Liabilities-1.94
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other-0.10
Other Working Capital0.04
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.60
Discontinued operations0.00
Net Cash flow from Operating Activities2.43
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Withdrawals From Restricted Cash-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.28
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-1.25
Other net0.00
Proceeds From Issuance Of Common Stock Net Of Expenses-
Proceeds From Issuance Of Commonstock Net O Fexpenses-
Proceeds From Issuance Of Rights Offering-
Proceeds From Short Swing Profit Judgment Offset With Settlement Expense-
Payment For Legal Professional And Registration Fees Incurred For Warrant Issue Capitalised-
Payment For Legal Professional And Registration Fees Incurred For Warrant Issue Capitalized-
Long Term Debt Paid-
Cash Paid For Taxes On Restricted Share Release-
Capital Expenditures Incurred But Not Yet Paid-
Sale Of Stock Consideration Received On Transaction-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow2.43
Total Cash Flow4.46
4 historic quarters locked

Sign in to unlock the full Fennec Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Fennec Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-095884

Figures are derived from filed reports and may be restated. Historical data is subject to revision.